James Wilding
James’ practice focuses on European Patent Office (EPO) prosecution and opposition work in the life sciences sector. He also has extensive experience with supplementary protection certificates (SPCs) and has prosecuted SPC applications covering a number of blockbuster drugs. · Mathys & Squire LLP
EnglandIntellectual Property, Patent Prosecution & Opposition
About
James focuses on European Patent Office (EPO) prosecution and opposition work in the life sciences sector and has extensive experience with supplementary protection certificates (SPCs), including prosecuting SPC portfolios and advising on SPC disputes. He regularly appears before EPO tribunals on behalf of clients and coordinates SPC/paediatric extension portfolios across Europe.
Practice areas
Intellectual PropertyPatent Prosecution & OppositionLife SciencesPharmaceuticalsBiotechnologySupplementary Protection Certificates (SPCs)
Office
Expertise
ImmunologyAntibody-based therapeuticsVaccinesDiagnosticsNucleic acid amplificationOligonucleotide therapyGene editingPlant extractsSupplementary Protection Certificates (SPCs)EPO opposition proceedingsPaediatric extensions/SPC portfolios
Education
- Master’s degree in Biochemistry, Oxford University
- Doctorate in the biochemistry of heart disease, Oxford University
- Post-doctoral research on cardiac disease, Université Paris-XI
Admissions
- Fellow of the Chartered Institute of Patent Attorneys (CIPA)
- Member of the European Patent Institute (EPI)